Azitra Inc Share Price
AZTRAzitra Inc Stock Performance
Open $0.17 | Prev. Close $0.16 | Circuit Range N/A |
Day Range $0.17 - $0.17 | Year Range $0.11 - $1.83 | Volume 4,240 |
Average Traded $0.17 |
Azitra Inc Share Price Chart
About Azitra Inc
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.
Azitra Inc Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Jun-26 | $0.17 | $0.17 | +0.00% |
29-Jun-26 | $0.17 | $0.17 | +6.17% |
26-Jun-26 | $0.16 | $0.16 | -1.82% |
25-Jun-26 | $0.18 | $0.17 | -20.29% |
24-Jun-26 | $0.20 | $0.21 | -1.90% |
23-Jun-26 | $0.20 | $0.21 | -10.59% |
22-Jun-26 | $0.23 | $0.24 | +12.38% |